Yi‐Hua Lai

The HLJ1 -targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer

Yi‐Hua Lai, Sung‐Liang Yu, Hsuan‐Yu Chen et al. · Carcinogenesis · 2013 · 47 citations · Full text

Chemoprevention Strategy, Tumour Growth, Hlj1 Expression +20

Dimethyl Sulfoxide Promotes the Multiple Functions of the Tumor Suppressor HLJ1 through Activator Protein-1 Activation in NSCLC Cells

Chi‐Chuan Wang, Sheng-Yi Lin, Yi‐Hua Lai et al. · PLoS ONE · 2012 · 45 citations · Full text

Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts

Pei-Jung Lee, Chao‐Chi Ho, Hao Ho et al. · Theranostics · 2021 · 29 citations · Full text

Real-world experience with Ropeginterferon-alpha 2b (Besremi) in Philadelphia-negative myeloproliferative neoplasms

Cih‐En Huang, Yuying Wu, Chia‐Chen Hsu et al. · Journal of the Formosan Medical Association · 2020 · 27 citations · Full text

Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods

Yung-Hao Wong, Chih‐Lung Lin, Ting-Shou Chen et al. · BMC Medical Genomics · 2015 · 26 citations · Full text